+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiplex Detection Immunoassays Market - Global Forecast 2026-2032- Product Image
Multiplex Detection Immunoassays Market - Global Forecast 2026-2032- Product Image
Sale

Multiplex Detection Immunoassays Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888894
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Multiplex Detection Immunoassays Market is projected to reach USD 2.59 Billion in 2026. It is expected to continue growing at a CAGR of 7.13%, reaching USD 3.91 Billion by 2032.

Multiplex Detection Immunoassays: Executive Overview

Multiplex detection immunoassays measure multiple analytes within a single biological sample, supporting applications in research, biomarker profiling, infectious-disease testing, immune monitoring, and clinical development. Their value is linked to reduced sample consumption, broader biological coverage, and the ability to generate more context from a single workflow. Adoption depends on assay performance, laboratory infrastructure, regulatory requirements, reimbursement conditions, and the availability of validated panels.

Assay Integration Is Reshaping Multiplex Testing Workflows

The landscape is shifting from single-analyte testing toward integrated workflows that combine broader panels, automation, digital result management, and complementary molecular or cellular methods. Laboratories are prioritizing reproducibility, simplified sample handling, lower hands-on time, and compatibility with existing instruments. At the same time, validation requirements are becoming more important as laboratories use multiplex results in translational research, clinical development, and increasingly complex diagnostic pathways.

Artificial Intelligence Strengthens Interpretation, Design, and Quality Control

Artificial intelligence can support multiplex immunoassays by identifying signal patterns, flagging anomalous results, optimizing panel composition, and improving interpretation of high-dimensional biomarker data. Machine-learning methods may also help laboratories manage batch effects and integrate immunoassay results with clinical, genomic, or imaging datasets. Effective deployment still requires well-curated training data, transparent performance assessment, controls against bias, cybersecurity safeguards, and human oversight for clinically consequential decisions.

Regional Insights: Infrastructure and Regulation Shape Adoption

North America benefits from advanced laboratory infrastructure, strong biomedical research activity, and established adoption of automated testing workflows. Europe emphasizes analytical validation, data governance, and cross-border regulatory alignment, while Asia-Pacific combines rapid healthcare-capacity development with strong research activity and diverse implementation environments. Latin America is shaped by uneven access to specialized equipment, public-health priorities, and the need for cost-efficient workflows. The Middle East is investing in laboratory modernization and precision-health capabilities, whereas Africa presents significant opportunities tied to infectious-disease surveillance, decentralized testing, workforce development, and reliable supply chains.

Group Insights: Economic and Institutional Blocs Have Distinct Priorities

ASEAN markets generally prioritize scalable laboratory capacity, infectious-disease applications, and adaptable procurement models. BRICS economies span large and diverse healthcare systems, creating demand for local research capability, resilient supply chains, and solutions suited to varied laboratory settings. The European Union places strong emphasis on harmonized quality, privacy, and regulatory compliance. G7 countries tend to focus on advanced translational research, automation, and evidence generation. GCC members are strengthening centralized and specialized healthcare infrastructure, while NATO countries may benefit from shared preparedness priorities involving biological surveillance, interoperability, and resilient diagnostics.

Country Insights: National Capacity Determines Use Cases and Scale

Australia combines strong biomedical research with geographically dispersed care needs. Brazil and Mexico face opportunities in public-health surveillance and laboratory modernization alongside access and procurement constraints. Canada emphasizes research collaboration, quality systems, and geographically inclusive testing. China and India are expanding scientific and healthcare capacity across highly varied regional systems. France, Germany, Italy, Spain, and the United Kingdom are shaped by mature laboratory networks, regulatory scrutiny, and demand for validated clinical and research applications. Japan and South Korea emphasize precision health, automation, and high-quality laboratory operations. Russia’s environment is influenced by domestic capacity, public-health priorities, and supply-chain considerations. The United States remains a major center for biomedical research, clinical development, and advanced laboratory adoption.

Priorities for Leaders: Validate, Integrate, and Build Resilience

Industry leaders should prioritize analytically validated panels with clearly defined intended uses, quality controls, and transparent performance metrics. Interoperability with laboratory information systems and automated sample workflows can improve operational value, while modular panel design can help laboratories adapt testing to changing research or public-health needs. Organizations should also establish governance for artificial intelligence, invest in workforce training, diversify critical supply arrangements, and develop region-specific evidence strategies that address regulatory, reimbursement, and infrastructure differences.

Research Methodology: Evidence-Led Market Assessment

This executive summary is based on a structured assessment of multiplex detection immunoassay technologies, applications, enabling workflows, adoption conditions, and geographic operating environments. The analysis organizes evidence across technology performance, laboratory requirements, regulatory considerations, healthcare priorities, and digital integration. Regional, group, and country perspectives are synthesized qualitatively from publicly verifiable institutional, scientific, regulatory, and health-system information. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Multiplex Value Depends on Trustworthy, Actionable Data

Multiplex detection immunoassays are becoming more relevant as laboratories seek richer biological insight from limited samples and more integrated testing processes. The strongest opportunities will arise where assay validation, workflow efficiency, data interpretation, and infrastructure readiness advance together. Leaders that combine robust evidence, responsible artificial-intelligence use, interoperability, and resilient implementation strategies will be better positioned to translate multiplex measurements into dependable research and healthcare decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Multiplex Detection Immunoassays Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Analyzers
7.2.2. Flow Cytometers
7.2.3. Readers
7.3. Kits & Reagents
7.3.1. Assay Beads
7.3.2. Detection Antibodies
7.3.3. Microarrays
7.3.4. Multiplex Assay Kits
7.4. Software & Services
7.4.1. Assay Development Services
7.4.2. Data Analysis Software
7.4.3. Support & Maintenance
8. Multiplex Detection Immunoassays Market, by Technology
8.1. Introduction
8.2. Bead Based Immunoassays
8.3. Flow Cytometry Based Immunoassays
8.4. Microarray Based Immunoassays
8.5. Planar Array Immunoassays
9. Multiplex Detection Immunoassays Market, by Application
9.1. Introduction
9.2. Autoimmune
9.2.1. Inflammatory Bowel Disease
9.2.2. Rheumatoid Arthritis
9.2.3. Systemic Lupus Erythematosus
9.3. Cardiovascular
9.3.1. Atherosclerosis
9.3.2. Heart Failure
9.3.3. Hypertension
9.4. Infectious Diseases
9.4.1. Bacterial Infections
9.4.1.1. E Coli
9.4.1.2. Salmonella
9.4.1.3. Tuberculosis
9.4.2. Parasitic Infections
9.4.2.1. Malaria
9.4.2.2. Schistosomiasis
9.4.2.3. Toxoplasmosis
9.4.3. Viral Infections
9.4.3.1. Hepatitis
9.4.3.2. HIV
9.4.3.3. Influenza
9.5. Neurological
9.5.1. Alzheimer’s Disease
9.5.2. Multiple Sclerosis
9.5.3. Parkinson’s Disease
9.6. Oncology
9.6.1. Breast Cancer
9.6.2. Colorectal Cancer
9.6.3. Lung Cancer
9.6.4. Prostate Cancer
10. Multiplex Detection Immunoassays Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Diagnostic Laboratories
10.5. Pharmaceutical & Biotechnology Companies
11. Multiplex Detection Immunoassays Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Multiplex Detection Immunoassays Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Multiplex Detection Immunoassays Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Multiplex Detection Immunoassays Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies, Inc.
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. Bio-Techne Corporation
16.6. Cell Signaling Technology, Inc.
16.7. Danaher Corporation
16.8. DiaSorin S.p.A.
16.9. Eurofins Scientific SE
16.10. F. Hoffmann-La Roche Ltd.
16.11. Illumina, Inc.
16.12. Merck KGaA
16.13. Promega Corporation
16.14. QIAGEN N.V.
16.15. Quanterix Corporation
16.16. QuidelOrtho Corporation
16.17. Randox Laboratories Ltd.
16.18. Revvity, Inc.
16.19. Seegene, Inc.
16.20. Siemens Healthineers AG
16.21. Standard BioTools Inc.
16.22. Sysmex Corporation
16.23. Thermo Fisher Scientific Inc.
16.24. Tosoh Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Multiplex Detection Immunoassays Market, Years Considered for the Study
FIGURE 2. Global Multiplex Detection Immunoassays Market, Research Design
FIGURE 3. Global Multiplex Detection Immunoassays Market, Research Framework
FIGURE 4. Global Multiplex Detection Immunoassays Market, Data Triangulation
FIGURE 5. Global Multiplex Detection Immunoassays Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Multiplex Detection Immunoassays Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Multiplex Detection Immunoassays Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Multiplex Detection Immunoassays Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Multiplex Detection Immunoassays Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Multiplex Detection Immunoassays Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Multiplex Detection Immunoassays Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Multiplex Detection Immunoassays Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Multiplex Detection Immunoassays Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Multiplex Detection Immunoassays Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Multiplex Detection Immunoassays Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Multiplex Detection Immunoassays Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Multiplex Detection Immunoassays Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Multiplex Detection Immunoassays Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Multiplex Detection Immunoassays Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Multiplex Detection Immunoassays Market Segmentation & Coverage
TABLE 2. Global Multiplex Detection Immunoassays Market Size, 2017-2032 (USD Million)
TABLE 3. Global Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Flow Cytometers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Flow Cytometers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Flow Cytometers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Readers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Readers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Readers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Kits & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Kits & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Kits & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Assay Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Assay Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Assay Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Detection Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Detection Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Detection Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Microarrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Microarrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Microarrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Multiplex Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Multiplex Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Multiplex Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Assay Development Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Assay Development Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Assay Development Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Support & Maintenance Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Support & Maintenance Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Support & Maintenance Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 44. Global Bead Based Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Bead Based Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Bead Based Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Flow Cytometry Based Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Flow Cytometry Based Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Flow Cytometry Based Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Microarray Based Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Microarray Based Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Microarray Based Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Planar Array Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Planar Array Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Planar Array Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Autoimmune Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Autoimmune Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Autoimmune Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Systemic Lupus Erythematosus Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Systemic Lupus Erythematosus Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Systemic Lupus Erythematosus Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Atherosclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Atherosclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Atherosclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Bacterial Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Bacterial Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Bacterial Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global E Coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global E Coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global E Coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Salmonella Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Salmonella Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Salmonella Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Tuberculosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Tuberculosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Tuberculosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Parasitic Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Parasitic Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Parasitic Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Malaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Malaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Malaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Schistosomiasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Schistosomiasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Schistosomiasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Toxoplasmosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Toxoplasmosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Toxoplasmosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Viral Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Viral Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Viral Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global HIV Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global HIV Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global HIV Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Neurological Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Neurological Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Neurological Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Alzheimer’s Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Alzheimer’s Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Alzheimer’s Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Parkinson’s Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Parkinson’s Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Parkinson’s Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Hospitals & Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Hospitals & Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Hospitals & Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. North America Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. North America Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. North America Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 188. North America Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 189. North America Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 190. North America Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 191. North America Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. North America Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 193. North America Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 194. North America Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 195. North America Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 196. North America Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 197. North America Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 198. North America Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 199. North America Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 200. North America Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. North America Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Latin America Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Latin America Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. Latin America Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 205. Latin America Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 206. Latin America Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 207. Latin America Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Latin America Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Latin America Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 210. Latin America Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 211. Latin America Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 212. Latin America Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 213. Latin America Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 214. Latin America Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 215. Latin America Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 216. Latin America Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 217. Latin America Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Latin America Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Europe Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Europe Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Europe Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 222. Europe Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 223. Europe Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 224. Europe Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. Europe Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Europe Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 227. Europe Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 228. Europe Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 229. Europe Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 230. Europe Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 231. Europe Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 232. Europe Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 233. Europe Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 234. Europe Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Europe Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Middle East Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 237. Middle East Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Middle East Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 239. Middle East Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 240. Middle East Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 241. Middle East Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Middle East Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Middle East Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 244. Middle East Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 245. Middle East Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 246. Middle East Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 247. Middle East Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 248. Middle East Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 249. Middle East Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 250. Middle East Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 251. Middle East Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Middle East Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Africa Multiplex Detection Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 254. Africa Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. Africa Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 256. Africa Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 257. Africa Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 258. Africa Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. Africa Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Africa Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 261. Africa Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 262. Africa Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 263. Africa Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 264. Africa Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 265. Africa Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 266. Africa Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 267. Africa Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 268. Africa Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Africa Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Global Multiplex Detection Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. ASEAN Multiplex Detection Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. ASEAN Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 273. ASEAN Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 274. ASEAN Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 275. ASEAN Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 276. ASEAN Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. ASEAN Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. ASEAN Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 279. ASEAN Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 280. ASEAN Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 281. ASEAN Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 282. ASEAN Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 283. ASEAN Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 284. ASEAN Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 285. ASEAN Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 286. ASEAN Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. ASEAN Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. GCC Multiplex Detection Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. GCC Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. GCC Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 291. GCC Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 292. GCC Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 293. GCC Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. GCC Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. GCC Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 296. GCC Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 297. GCC Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 298. GCC Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 299. GCC Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 300. GCC Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 301. GCC Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 302. GCC Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 303. GCC Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. GCC Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 305. European Union Multiplex Detection Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. European Union Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. European Union Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 308. European Union Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 309. European Union Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 310. European Union Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 311. European Union Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. European Union Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 313. European Union Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 314. European Union Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 315. European Union Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 316. European Union Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 317. European Union Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 318. European Union Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 319. European Union Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. European Union Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. European Union Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 322. BRICS Multiplex Detection Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 323. BRICS Multiplex Detection Immunoassays Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 324. BRICS Multiplex Detection Immunoassays Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 325. BRICS Multiplex Detection Immunoassays Market Size, by Kits & Reagents, 2017-2032 (USD Million)
TABLE 326. BRICS Multiplex Detection Immunoassays Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 327. BRICS Multiplex Detection Immunoassays Market Size, by Technology, 2017-2032 (USD Million)
TABLE 328. BRICS Multiplex Detection Immunoassays Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. BRICS Multiplex Detection Immunoassays Market Size, by Autoimmune, 2017-2032 (USD Million)
TABLE 330. BRICS Multiplex Detection Immunoassays Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 331. BRICS Multiplex Detection Immunoassays Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 332. BRICS Multiplex Detection Immunoassays Market Size, by Bacterial Infections, 2017-2032 (USD Million)
TABLE 333. BRICS Multiplex Detection Immunoassays Market Size, by Parasitic Infections, 2017-2032 (USD Million)
TABLE 334. BRICS Multiplex Detection Immunoassays Market Size, by Viral Infections, 2017-2032 (USD Million)
TABLE 335. BRICS Multiplex Detection Immunoassays Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 336. BRICS Multiplex Detection Immunoassays Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 337. BRICS Multiplex Detection Immunoassays Market Size, by End User, 2017-2032 (USD Million)
TABLE 338. BRICS Multiplex Detection Immunoassays Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. G7 Multiplex Detection Immunoassays Mar

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc.
  • Seegene, Inc.
  • Siemens Healthineers AG
  • Standard BioTools Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

Related Topics

Related Reports

Multiplex Detection Immunoassays - Global Strategic Business Report - Product Image

Multiplex Detection Immunoassays - Global Strategic Business Report

  • Report
  • 257 Pages
  • Global
From
Immunoassays - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Immunoassays - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Immunoassay Interference Blocker - Global Strategic Business Report - Product Image

Immunoassay Interference Blocker - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From
Immunoassay Analyzers Market - Global Forecast 2026-2032 - Product Image

Immunoassay Analyzers Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2026 - Product Image

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Multiplex Detection Immunoassays Market

Within the field of In Vitro Diagnostics (IVD), multiplex detection immunoassays represent a technological advancement enabling the simultaneous detection and quantification of multiple analytes, such as proteins, pathogens, or biomarkers, from a single sample. This approach contrasts with traditional methods that require separate tests for each analyte. The increased efficiency and comprehensive data generated by multiplex immunoassays facilitate a more robust understanding of patient samples, aiding in disease diagnosis, monitoring, and management. The use of multiplex detection immunoassays spans various applications, including infectious disease testing, autoimmune disease diagnostics, allergy testing, oncology, and pharmacogenomics, among others. These tests employ various platforms like planar arrays or bead-based systems, with detection methods that include fluorescent, electrochemiluminescent, or colorimetric readouts. The ability of multiplex immunoassays to provide quick and reliable results is valued in both clinical and research settings, leading to their integration into laboratories and hospitals. Some companies that operate in the multiplex detection immunoassays market are Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthineers, Luminex Corporation, and F. Hoffmann-La Roche Ltd. These companies offer a range of products and services tailored to the needs of IVD, including multiplex assay kits, reagents, instruments, and software for data analysis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.